HALOTHANE MEDIATED INHIBITION OF CALMODULIN-NEUROPEPTIDE BINDING | ||||
| Zagazig Journal of Pharmaceutical Sciences | ||||
| Article 19, Volume 5, Issue 2, December 1996, Page 134-137 PDF (2.41 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/zjps.1996.185036 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohamed Adel El-Sayed  1; Manuchair Ebadi2; Sudhire Paul2
| ||||
| 1Dept. of Pharmacology, Benha Faculty of Medicine, Zagazig University | ||||
| 2Dept. of Anesthesiology, University of Nebraska Medical Center, Omaha, USA | ||||
| Abstract | ||||
| Binding of volatile anesthetics by proteins has been proposed as a mechanism of anesthesia. There is no evidence, however, that anesthetics at clinically relevant concentrations can interact directly with lipid - free preparations of receptors or signal transducing proteins. Calmodulin is a key regulator of metabolism in neurons and muscle cells. This study describes the effects of halothane on the binding of the neuropeptide vasoactive intestinal peptide (VIP) by calmodulin. It was found that : (1) Saturable complexation of (tyr10-125 1)VIP by calmodulin was absolutely Ca2+ -dependent, requiring mM metal concentrations for optimal binding. (2) Halothane produced a dose - dependent, biphasic inhibition of VIP - calmodulin complexation . Relatively low concentrations of halothane (0.15-0.27 mM) inhibited the complexation strongly up to 67% inhibition. (3) The inhibitory concentrations of halothane did not influence binding of VIP by monoclonal antibody. It could be concluded that calmodulin may be the target molecule for halothane and that the mechanism of anesthesia by halothane involves direct interaction with cellular signal-transducing proteins . | ||||
|
Statistics Article View: 80 PDF Download: 46 |
||||
